Abstract
Autoimmunity happens when the immune system recognizes autoantigens as foreign harmful agents. It is a multifactorial condition predominantly resulting from autoreactive B cells and T cells. Inflammatory processes and excessive cytokine production are mainly involved in the pathogenesis of autoimmune disease. Many factors including environmental and genetic factors play role in autoimmune diseases. There is a myriad of elements related to autoimmunity including cross-reactivity with autoantigens, defect in tolerance, and lymphoproliferative dysregulation. There are two types of autoimmune diseases. Tissue-specific and systemic autoimmune disorders happen through the host immune reaction against a specific antigen in a particular tissue and/or multiple organs and tissues, respectively. In tissue-specific autoimmune diseases, both T cells and B cells are engaged in recognition of self-antigens. Autoimmune thyroiditis, type 1 diabetes, multiple sclerosis, inflammatory bowel disease, and autoimmune liver diseases are examples of this type of autoimmunity. Systemic autoimmune diseases are characterized by the production of autoreactive antibodies against different autoantigens including nuclear components, cell surface molecules, and intracellular matrix proteins. Systemic lupus erythematosus, Sjögren’s syndrome, and rheumatoid arthritis are examples of systemic autoimmune disorders. Recent research found that nutrition and dietary factors are important for the development of autoimmunity. A healthy diet can help the immune system to better control discrimination of self from nonself. However, the exact effects of nutrients on the initiation of an autoimmune condition are not clear. Although there is no specific diet for the treatment of autoimmune diseases, there are nutrients known to influence functioning of the immune system. Some can affect T-cell proliferation and Th1 activation that are involved in the development of autoimmunity. An anti-inflammatory diet limited in pro-inflammatory compounds can be used to control autoimmunity. Nutrients can prevent inflammation through restriction of the production of pro-inflammatory cytokines including IFN-γ and through promotion of regulatory T-cell function.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
References
Burnet FM. A modification of Jerne’s theory of antibody production using the concept of clonal selection. Aust J Sci. 1957;20(3):67–9.
Rose NR. Autoimmune diseases: tracing the shared threads. Hosp Pract. 1997;32(4):147–54.
Ray S, Sonthalia N, Kundu S, Ganguly S. Autoimmune disorders: an overview of molecular and cellular basis in today’s perspective. J Clin Cell Immunol. 2012;S10:003.
Vojdani A. Antibodies as predictors of complex autoimmune diseases. Int J Immunopathol Pharmacol. 2008;21(2):267–78.
Hayter SM, Cook MC. Updated assessment of the prevalence, spectrum and case definition of autoimmune disease. Autoimmun Rev. 2012;11(10):754–65.
Klein SL. The effects of hormones on sex differences in infection: from genes to behavior. Neurosci Biobehav Rev. 2000;24(6):627–38.
Campbell AW. Autoimmunity and the gut. Autoimmune Dis. 2014;2014:1.
Rose N. An immunology primer. Proceedings from sex differences in immunology and autoimmunity, vol. 8. Boston: Society for Women’s Health Research; 2001. p. 7–9.
Mangan PR, Harrington LE, O’quinn DB, Helms WS, Bullard DC, Elson CO, et al. Transforming growth factor-β induces development of the TH17 lineage. Nature. 2006;441(7090):231–4.
Lerner A, Jeremias P, Matthias T. The world incidence and prevalence of autoimmune diseases is increasing. Int J Celiac Dis. 2015;3(4):151–5.
Rook GA. Hygiene hypothesis and autoimmune diseases. Clin Rev Allergy Immunol. 2012;42(1):5–15.
Manzel A, Muller DN, Hafler DA, Erdman SE, Linker RA, Kleinewietfeld M. Role of “Western diet” in inflammatory autoimmune diseases. Curr Allergy Asthma Rep. 2014;14(1):404.
Nossal G. A purgative mastery. Nature. 2001;412(6848):685–6.
Barrett JC, Clayton DG, Concannon P, Akolkar B, Cooper JD, Erlich HA, et al. Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes. Nat Genet. 2009;41(6):703–7.
Criswell LA, Pfeiffer KA, Lum RF, Gonzales B, Novitzke J, Kern M, et al. Analysis of families in the multiple autoimmune disease genetics consortium (MADGC) collection: the PTPN22 620W allele associates with multiple autoimmune phenotypes. Am J Hum Genet. 2005;76(4):561–71.
Tomer Y. Unraveling the genetic susceptibility to autoimmune thyroid diseases: CTLA-4 takes the stage. Thyroid: official journal of the American Thyroid Association. 2001;11(2):167–9. https://doi.org/10.1089/105072501300042884.
Klein J, Sato A. The HLA system. N Engl J Med. 2000;343(10):702–9.
Davidson A, Diamond B. Autoimmune diseases. N Engl J Med. 2001;345(5):340–50.
Mackay IR. Tolerance and autoimmunity. West J Med. 2001;174(2):118–23.
Rose N, Mackay I. Molecular mimicry: a critical look at exemplary instances in human diseases. Cell Mol Life Sci. 2000;57(4):542–51.
Rose NR, editor. The role of infection in the pathogenesis of autoimmune disease. Semin Immunol. 1998;10(1):5–13: Elsevier.
Mitchell TC, Hildeman D, Kedl RM, Teague TK, Schaefer BC, White J, et al. Immunological adjuvants promote activated T cell survival via induction of Bcl-3. Nat Immunol. 2001;2(5):397–402.
Bernal A, Proft T, Fraser JD, Posnett DN. Superantigens in human disease. J Clin Immunol. 1999;19(3):149–57.
Rose NR. Insights into mechanisms of autoimmune disease based on clinical findings. In: Autoimmune reactions. Totowa: Humana Press; 1999. p. 5–17.
Tsokos GC. Systemic lupus erythematosus. N Engl J Med. 2011;365(22):2110–21.
von Muhlen CA, Tan EM. Autoantibodies in the diagnosis of systemic rheumatic diseases. Semin Arthritis Rheum. 1995;24(5):323–58.
Huang W, Connor E, Rosa TD, Muir A, Schatz D, Silverstein J, et al. Although DR3-DQB1∗0201 may be associated with multiple component diseases of the autoimmune polyglandular syndromes, the human leukocyte antigen DR4-DQB1∗0302 haplotype is implicated only in beta-cell autoimmunity. J Clin Endocrinol Metab. 1996;81(7):2559–63.
Lesage S, Goodnow CC. Organ-specific autoimmune disease: a deficiency of tolerogenic stimulation. J Exp Med. 2001;194(5):f31–f6.
Swank RL, Lerstad O, Strøm A, Backer J. Multiple sclerosis in rural Norway: its geographic and occupational incidence in relation to nutrition. N Engl J Med. 1952;246(19):721–8.
Ouchi N, Parker JL, Lugus JJ, Walsh K. Adipokines in inflammation and metabolic disease. Nat Rev Immunol. 2011;11(2):85.
De Rosa V, Procaccini C, La Cava A, Chieffi P, Nicoletti GF, Fontana S, et al. Leptin neutralization interferes with pathogenic T cell autoreactivity in autoimmune encephalomyelitis. J Clin Investig. 2006;116(2):447.
Winer S, Paltser G, Chan Y, Tsui H, Engleman E, Winer D, et al. Obesity predisposes to Th17 bias. Eur J Immunol. 2009;39(9):2629–35.
Brown AC. Lupus erythematosus and nutrition: a review of the literature. J Ren Nutr. 2000;10(4):170–83.
Sinigaglia L, Varenna M, Binelli L, Zucchi F, Ghiringhella D, Gallazzi M, et al. Determinants of bone mass in systemic lupus erythematosus: a cross sectional study on premenopausal women. J Rheumatol. 1999;26(6):1280–4.
Cojocaru M, Cojocaru IM, Silosi I. Multiple autoimmune syndrome. Maedica. 2010;5(2):132–4.
Nerup J, Mandrup-Poulsen T, Mølvig J, Helqvist S, Wogensen L, Egeberg J. Mechanisms of pancreatic beta-cell destruction in type I diabetes. Diabetes Care. 1988;11:16–23.
Delgado-Aros S, Locke GR, Camilleri M, Talley NJ, Fett S, Zinsmeister AR, et al. Obesity is associated with increased risk of gastrointestinal symptoms: a population-based study. Am J Gastroenterol. 2004;99(9):1801–6.
Campillo B, Bories PN, Leluan M, Pornin B, Devanlay M, Fouet P. Short-term changes in energy metabolism after 1 month of a regular oral diet in severely malnourished cirrhotic patients. Metabolism. 1995;44(6):765–70.
Atarashi K, Tanoue T, Shima T, Imaoka A, Kuwahara T, Momose Y, et al. Induction of colonic regulatory T cells by indigenous Clostridium species. Science. 2011;331(6015):337–41.
Morgan XC, Tickle TL, Sokol H, Gevers D, Devaney KL, Ward DV, et al. Dysfunction of the intestinal microbiome in inflammatory bowel disease and treatment. Genome Biol. 2012;13(9):R79.
Qin J, Li Y, Cai Z, Li S, Zhu J, Zhang F, et al. A metagenome-wide association study of gut microbiota in type 2 diabetes. Nature. 2012;490(7418):55–60.
Simopoulos AP. Omega-3 fatty acids in inflammation and autoimmune diseases. J Am Coll Nutr. 2002;21(6):495–505.
Medawar P, Hunt R, Mertin J. An influence of diet on transplantation immunity. Proc R Soc Lond B Biol Sci. 1979;206(1164):265–80.
Harbige LS. Dietary n-6 and n-3 fatty acids in immunity and autoimmune disease. Proc Nutr Soc. 1998;57(4):555–62.
Fernandes G, Chandrasekar B, Luan X, Troyer DA. Modulation of antioxidant enzymes and programmed cell death by n-3 fatty acids. Lipids. 1996;31(1):S91–S6.
Homsy J, Morrow W, Levy J. Nutrition and autoimmunity: a review. Clin Exp Immunol. 1986;65(3):473.
Patavino T, Brady DM. Natural medicine and nutritional therapy as an alternative treatment in systemic lupus erythematosus. Altern Med Rev. 2001;6(5):460–71.
Wietmarschen H, van der Greef J. Metabolite space of rheumatoid arthritis. Br J Med Med Res. 2012;2:469.
Grabowski G, Grant JP. Nutritional support in patients with systemic scleroderma. JPEN J Parenter Enteral Nutr. 1989;13(2):147–51.
Rosen A, Casciola-Rosen L. Autoantigens in systemic autoimmunity: critical partner in pathogenesis. J Intern Med. 2009;265(6):625–31.
Petriello MC, Newsome B, Hennig B. Influence of nutrition in PCB-induced vascular inflammation. Environ Sci Pollut Res Int. 2014;21(10):6410–8.
Bates D, Fawcett P, Shaw D, Weightman D. Trail of polyunsaturated fatty acids in non-relapsing multiple sclerosis. Br Med J. 1977;2(6092):932.
Andersen V, Olsen A, Carbonnel F, Tjønneland A, Vogel U. Diet and risk of inflammatory bowel disease. Dig Liver Dis. 2012;44(3):185–94.
Noriega BS, Sanchez-Gonzalez MA, Salyakina D, Coffman J. Understanding the impact of omega-3 rich diet on the gut microbiota. Case Rep Med. 2016;2016:1.
Hudert CA, Weylandt KH, Lu Y, Wang J, Hong S, Dignass A, et al. Transgenic mice rich in endogenous omega-3 fatty acids are protected from colitis. Proc Natl Acad Sci. 2006;103(30):11276–81.
Phipps RP, Stein SH, Roper RL. A new view of prostaglandin E regulation of the immune response. Immunol Today. 1991;12(10):349–52.
Harbige L, Yeatman N, Amor S, Crawford M. Prevention of experimental autoimmune encephalomyelitis in Lewis rats by a novel fungal source of γ-linolenic acid. Br J Nutr. 1995;74(5):701–15.
Meade CJ, Mertin J, Sheena J, Hunt R. Reduction by linoleic acid of the severity of experimental allergic encephalomyelitis in the guinea pig. J Neurol Sci. 1978;35(2):291–308.
Vojdani A. A potential link between environmental triggers and autoimmunity. Autoimmune Dis. 2014;2014:1–18.
Shetty PS. Nutrition, immunity and infection. Wallingford: CABI; 2010.
Makela R, Makila H, Peltomaa R. Dietary therapy in patients with inflammatory arthritis. Altern Ther Health Med. 2017;23(1):34–9.
Verdu EF, Galipeau HJ, Jabri B. Novel players in coeliac disease pathogenesis: role of the gut microbiota. Nat Rev Gastroenterol Hepatol. 2015;12(9):497–506.
Jiskra J, Limanova Z, Vanickova Z, Kocna P. IgA and IgG antigliadin, IgA anti-tissue transglutaminase and antiendomysial antibodies in patients with autoimmune thyroid diseases and their relationship to thyroidal replacement therapy. Physiol Res. 2003;52(1):79–88.
Catassi C, Guerrieri A, Bartolotta E, Coppa G, Giorgi P. Antigliadin antibodies at onset of diabetes in children. Lancet. 1987;330(8551):158.
Sukkar SG, Rossi E. Oxidative stress and nutritional prevention in autoimmune rheumatic diseases. Autoimmun Rev. 2004;3(3):199–206.
Araujo V, Arnal C, Boronat M, Ruiz E, Dominguez C. Oxidant—antioxidant imbalance in blood of children with juvenile rheumatoid arthritis. Biofactors. 1998;8(1–2):155–9.
Comstock G, Burke A, Hoffman S, Helzlsouer K, Bendich A, Masi A, et al. Serum concentrations of α tocopherol, β carotene, and retinol preceding the diagnosis of rheumatoid arthritis and systemic lupus erythematosus. Ann Rheum Dis. 1997;56(5):323–5.
Edmonds S, Winyard P, Guo R, Kidd B, Merry P, Langrish-Smith A, et al. Putative analgesic activity of repeated oral doses of vitamin E in the treatment of rheumatoid arthritis. Results of a prospective placebo controlled double blind trial. Ann Rheum Dis. 1997;56(11):649–55.
Mirvish SS. Effects of vitamins C and E on N-nitroso compound formation, carcinogenesis, and cancer. Cancer. 1986;58(S8):1842–50.
Gärtner R, Gasnier BC, Dietrich JW, Krebs B, Angstwurm MW. Selenium supplementation in patients with autoimmune thyroiditis decreases thyroid peroxidase antibodies concentrations. J Clin Endocrinol Metabol. 2002;87(4):1687–91.
Contempre B, Duale N, Dumont JE, Ngo B, Diplock A, Vanderpas J. Effect of selenium supplementation on thyroid hormone metabolism in an iodine and selenium deficient population. Clin Endocrinol. 1992;36(6):579–83.
Contempre B, Le Moine O, Dumont JE, Denef J-F, Many M-C. Selenium deficiency and thyroid fibrosis. A key role for macrophages and transforming growth factor β (TGF-β). Mol Cell Endocrinol. 1996;124(1):7–15.
Klack K, Bonfa E, Borba Neto EF. Diet and nutritional aspects in systemic lupus erythematosus. Rev Bras Reumatol. 2012;52(3):384–408.
Tamer G, Arik S, Tamer I, Coksert D. Relative vitamin D insufficiency in Hashimoto’s thyroiditis. Thyroid. 2011;21(8):891–6.
Jyotsna VP, Sahoo A, Singh AK, Sreenivas V, Gupta N. Bone mineral density in patients of graves disease pre-& post-treatment in a predominantly vitamin D deficient population. Indian J Med Res. 2012;135(1):36.
Drocourt L, Ourlin J-C, Pascussi J-M, Maurel P, Vilarem M-J. Expression of cyp3a4, cyp2b6, andcyp2c9 is regulated by the vitamin d receptor pathway in primary human hepatocytes. J Biol Chem. 2002;277(28):25125–32.
Jeffery LE, Burke F, Mura M, Zheng Y, Qureshi OS, Hewison M, et al. 1, 25-Dihydroxyvitamin D3 and IL-2 combine to inhibit T cell production of inflammatory cytokines and promote development of regulatory T cells expressing CTLA-4 and FoxP3. J Immunol. 2009;183(9):5458–67.
Virtanen SM, Knip M. Nutritional risk predictors of β cell autoimmunity and type 1 diabetes at a young age. Am J Clin Nutr. 2003;78(6):1053–67.
Klack K, De Carvalho J. Dietetic issues in antiphospholipid syndrome. Rheumatol Int. 2013;33(3):823–4.
Dean S. Medical nutrition therapy for thyroid and related disorders. In: Krause’s food, nutrition, & diet therapy. 13th ed. Philadelphia: Saunders; 2008. p. 711–24.
Barkoukis H, Fiedler KM, Lerner E. A combined high-fiber, low-glycemic index diet normalizes glucose tolerance and reduces hyperglycemia and hyperinsulinemia in adults with hepatic cirrhosis. J Acad Nutr Diet. 2002;102(10):1503.
Kleinewietfeld M, Manzel A, Titze J, Kvakan H, Yosef N, Linker RA, et al. Sodium chloride drives autoimmune disease by the induction of pathogenic TH17 cells. Nature. 2013;496(7446):518–22.
Wu C, Yosef N, Thalhamer T, Zhu C, Xiao S, Kishi Y, et al. Induction of pathogenic TH17 cells by inducible salt-sensing kinase SGK1. Nature. 2013;496(7446):513–7.
Helgason T, Jonasson M. Evidence for a food additive as a cause of ketosis-prone diabetes. Lancet. 1981;318(8249):716–20.
Hald S, Schioldan AG, Moore ME, Dige A, Lærke HN, Agnholt J, et al. Effects of arabinoxylan and resistant starch on intestinal microbiota and short-chain fatty acids in subjects with metabolic syndrome: a randomised crossover study. PLoS One. 2016;11(7):e0159223.
Lerner A, Matthias T. Changes in intestinal tight junction permeability associated with industrial food additives explain the rising incidence of autoimmune disease. Autoimmun Rev. 2015;14(6):479–89.
Wu SV, Hui H. Treat your bug right. Front Physiol. 2011;2:9.
Matsuzaki T, Takagi A, Ikemura H, Matsuguchi T, Yokokura T. Intestinal microflora: probiotics and autoimmunity. J Nutr. 2007;137(3):798S–802S.
Barnes MJ, Powrie F. Regulatory T cells reinforce intestinal homeostasis. Immunity. 2009;31(3):401–11.
Rescigno M, Di Sabatino A. Dendritic cells in intestinal homeostasis and disease. J Clin Invest. 2009;119(9):2441.
Gensollen T, Iyer SS, Kasper DL, Blumberg RS. How colonization by microbiota in early life shapes the immune system. Science. 2016;352(6285):539–44.
Ríos-Covián D, Ruas-Madiedo P, Margolles A, Gueimonde M, de los Reyes-Gavilán CG, Salazar N. Intestinal short chain fatty acids and their link with diet and human health. Front Microbiol. 2016;7:185.
Upadhyaya B, McCormack L, Fardin-Kia AR, Juenemann R, Nichenametla S, Clapper J, et al. Impact of dietary resistant starch type 4 on human gut microbiota and immunometabolic functions. Sci Rep. 2016;6:28797.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2019 Springer Nature Switzerland AG
About this chapter
Cite this chapter
Arabi, S., Molazadeh, M., Rezaei, N. (2019). Nutrition, Immunity, and Autoimmune Diseases. In: Mahmoudi, M., Rezaei, N. (eds) Nutrition and Immunity. Springer, Cham. https://doi.org/10.1007/978-3-030-16073-9_21
Download citation
DOI: https://doi.org/10.1007/978-3-030-16073-9_21
Published:
Publisher Name: Springer, Cham
Print ISBN: 978-3-030-16072-2
Online ISBN: 978-3-030-16073-9
eBook Packages: MedicineMedicine (R0)